CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

OXGN's EPS Net Growth by Quarter and Year

Mateon Therapeutics Inc's EPS Net results by quarter and year




OXGN EPS Net (in $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -0.06 -0.02 -0.15
III Quarter September - -0.01 -0.03 -0.15
II Quarter June 0.01 -0.02 -0.09 -0.12
I Quarter March -0.05 -0.02 -0.13 -0.14
FY   -0.04 -0.11 -0.27 -0.56



OXGN EPS Net second quarter 2020 Y/Y Growth Comment
Mateon Therapeutics Inc in the second quarter achieved EPS Net of $ 0.01 compare to EPS net loss recorded in same quarter a year ago.

According to the results reported in the second quarter, Mateon Therapeutics Inc achieved the best EPS Net growth in Biotechnology & Drugs industry. While Mateon Therapeutics Inc' s EPS Net no change of % ranks overall at the positon no. 0 in the second quarter.




OXGN EPS Net ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Mateon Therapeutics Inc's second quarter 2020 EPS Net $ 0.01 OXGN's Income Statement
Mateon Therapeutics Inc's second quarter 2019 EPS Net $ -0.02 Quarterly OXGN's Income Statement
New: More OXGN's historic EPS Net Growth >>


OXGN EPS Net (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Mateon Therapeutics Inc's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's II. Quarter Q/Q EPS Net Comment
Improvement II. Quarter 2020where Mateon Therapeutics Inc posted EPS Net of $ 0.01 should be considered as a beginning of better business climet.Mateon Therapeutics Inc announced in the II. Quarter 2020 EPS Net of $ 0.01 compare to EPS net loss recorded in previos quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential EPS Net growth. While Mateon Therapeutics Inc's EPS Net growth quarter on quarter, overall rank is 0.


EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's II. Quarter Q/Q EPS Net Comment
This turnaround II. Quarter 2020where Mateon Therapeutics Inc delivered EPS Net of $ 0.01 may is starting point of better business climet.Mateon Therapeutics Inc announced in the II. Quarter 2020 EPS Net of $ 0.01 compare to EPS net loss recorded in previos quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential EPS Net growth. While Mateon Therapeutics Inc's EPS Net growth quarter on quarter, overall rank is 0.


Mateon Therapeutics Inc's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
Cumulative EPS Net 12 Months Ending $ -0.11 $ -0.14 $ -0.11 $ -0.07 $ -0.09
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Mateon Therapeutics Inc' has realized cumulative trailing twelve months EPS net loss of $ -0 in the Jun 30 2020 period.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Mateon Therapeutics Inc' has realized cumulative trailing twelve months EPS net loss of $ -0 in the Jun 30 2020 period.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Biotechnology & Drugs Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
OXGN's EPS Net Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for OXGN's Competitors
EPS Net Growth for Mateon Therapeutics Inc's Suppliers
EPS Net Growth for OXGN's Customers

You may also want to know
OXGN's Annual Growth Rates OXGN's Profitability Ratios OXGN's Asset Turnover Ratio OXGN's Dividend Growth
OXGN's Roe OXGN's Valuation Ratios OXGN's Financial Strength Ratios OXGN's Dividend Payout Ratio
OXGN's Roa OXGN's Inventory Turnover Ratio OXGN's Growth Rates OXGN's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Jun 30 2020 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Jun 30 2020
Davita Inc -1.22 %$ -1.220 
Lifevantage Corp -3.98 %$ -3.979 
Msa Safety Inc -8.91 %$ -8.911 
Atrion Corporation -9.65 %$ -9.653 
Catalyst Pharmaceuticals Inc -10.00 %$ -10.000 
Medpace Holdings inc -12.33 %$ -12.329 
Amgen Inc -14.57 %$ -14.566 
Acadia Healthcare Company Inc -16.36 %$ -16.364 
Icu Medical Inc -16.98 %$ -16.981 
Quest Diagnostics Inc -18.07 %$ -18.072 
Vanda Pharmaceuticals Inc -23.81 %$ -23.810 
Lemaitre Vascular Inc -26.09 %$ -26.087 
Baxter International Inc -27.27 %$ -27.273 
Bruker Corporation -30.43 %$ -30.435 
Pfizer Inc -31.46 %$ -31.461 
Johnson and Johnson -34.62 %$ -34.615 
Becton Dickinson And Company -35.76 %$ -35.762 
Phibro Animal Health Corp -35.94 %$ -35.942 
Abbott Laboratories -46.43 %$ -46.429 
United Therapeutics Corporation -48.28 %$ -48.283 
Abiomed Inc -49.22 %$ -49.223 
China Health Industries Holdings Inc -52.54 %$ -52.544 
Neurotrope inc -58.06 %$ -58.065 
Semler Scientific Inc -59.38 %$ -59.375 
Jrsis Health Care Corp -60.32 %$ -60.319 
Utah Medical Products Inc -61.70 %$ -61.702 
Encompass Health Corporation -63.04 %$ -63.043 
Syneos Health Inc -63.64 %$ -63.636 
Inogen Inc -73.33 %$ -73.333 
Biotelemetry Inc -73.91 %$ -73.913 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BIGC's Profile

Stock Price

BIGC's Financials

Business Description

Fundamentals

Charts & Quotes

BIGC's News

Suppliers

BIGC's Competitors

Customers & Markets

Economic Indicators

BIGC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071